SCOPUS 정보 검색 플랫폼

Volumn 34, Issue 2, 2006, Pages 144-146

Olazapine induced neuroleptic malignant syndrome

b NONE (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

BENZODIAZEPINE DERIVATIVE; NEUROLEPTIC AGENT; OLANZAPINE;

AGED; ANXIETY; CASE REPORT; FEMALE; HUMAN; LETTER; NEUROLEPTIC MALIGNANT SYNDROME; PATHOPHYSIOLOGY;

AGED; ANTIPSYCHOTIC AGENTS; ANXIETY; BENZODIAZEPINES; FEMALE; HUMANS; NEUROLEPTIC MALIGNANT SYNDROME;

EID: 33646349006 PISSN: 11399287 EISSN: None Source Type: Journal
DOI: None Document Type: Letter

Times cited : (2)

References (10)

1
- 0029364447
- Síndrome neuroléptico maligno: Una revisión bibliográfica
- Crespo Facorro B, Carbonell Masia C. Síndrome neuroléptico maligno: una revisión bibliográfica. Act Luso-Esp Neurol Psiq Cienc Afines 1995;23:273-8.
- (1995) Act Luso-Esp Neurol Psiq Cienc Afines , vol.23 , pp. 273-278
- Crespo Facorro, B.¹ Carbonell Masia, C.²

2
- 0036233952
- Atypical neuroleptic sindrome associated with olanzapine
- Reeves RR, Torres RA, Liberto V, Hart RH. Atypical neuroleptic sindrome associated with olanzapine. Pharmacotherapy 2002; 22:641-4.
- (2002) Pharmacotherapy , vol.22 , pp. 641-644
- Reeves, R.R.¹ Torres, R.A.² Liberto, V.³ Hart, R.H.⁴

3
- 2442436578
- Neuroleptic malignant syndrome and atypical antipsychotic drugs
- Ananth J, Parameswaran S, Gunatilake S, Burgoyne K, Sidhom T. Neuroleptic malignant syndrome and atypical antipsychotic drugs. J Clin Psychiatry 2004;65:464-70.
- (2004) J Clin Psychiatry , vol.65 , pp. 464-470
- Ananth, J.¹ Parameswaran, S.² Gunatilake, S.³ Burgoyne, K.⁴ Sidhom, T.⁵

4
- 0032450594
- Neuroleptic malignant syndrome associated with olanzapine
- Jonson V, Bruxner G. Neuroleptic malignant syndrome associated with olanzapine. Aust N Z J Psychiatry 1998;32:884-6.
- (1998) Aust N Z J Psychiatry , vol.32 , pp. 884-886
- Jonson, V.¹ Bruxner, G.²

5
- 2942580714
- Recognizing neuroleptic malignant syndrome
- Rosebush PI, Garside S, Mazurek MF. Recognizing neuroleptic malignant syndrome. CMAJ 2004;170:1645.
- (2004) CMAJ , vol.170 , pp. 1645
- Rosebush, P.I.¹ Garside, S.² Mazurek, M.F.³

6
- 0042530500
- Life threatening neuroleptic malignant syndrome due to olanzapine
- Kopf A, Koster J, Schulz A, Kromker H, Becker T. Life threatening neuroleptic malignant syndrome due to olanzapine. Psychiatr Prax 2003;30:279-82.
- (2003) Psychiatr Prax , vol.30 , pp. 279-282
- Kopf, A.¹ Koster, J.² Schulz, A.³ Kromker, H.⁴ Becker, T.⁵

7
- 0033535429
- Neuroleptic malignant syndrome after treatment with olanzapine
- Emborg C. Neuroleptic malignant syndrome after treatment with olanzapine. Ugeskr Laeger 1999;161:1424-5.
- (1999) Ugeskr Laeger , vol.161 , pp. 1424-1425
- Emborg, C.¹

8
- 0035018959
- Neuroleptic malignant syndrome during a change from haloperidol to risperidone
- Reeves RR, Mack JE, Torres RA. Neuroleptic malignant syndrome during a change from haloperidol to risperidone. Ann Pharmacother 2001;35:698-701.
- (2001) Ann Pharmacother , vol.35 , pp. 698-701
- Reeves, R.R.¹ Mack, J.E.² Torres, R.A.³

9
- 0037308255
- Olanzapine induced typical neuroleptic malignant syndrome
- Goveas JS, Adriana H. Olanzapine induced typical neuroleptic malignant syndrome. J Clin Psychopharmacol 2003;23:101-2.
- (2003) J Clin Psychopharmacol , vol.23 , pp. 101-102
- Goveas, J.S.¹ Adriana, H.²

10
- 0642310446
- Neuroleptic malignant syndrome in a patient treated with olanzapine
- Horni G, Meirik K, Lund MB. Neuroleptic malignant syndrome in a patient treated with olanzapine. Tidsskr Nor Laegeforen 2003; 123:2867-9.
- (2003) Tidsskr Nor Laegeforen , vol.123 , pp. 2867-2869
- Horni, G.¹ Meirik, K.² Lund, M.B.³

* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.